Join us for this free knowledge sharing seminar, designed for biopharma companies developing injectable therapies considering the transition from vials to prefilled syringes (PFS) and ultimately to integrated drug–device combination (DDC) products.

As injectable drug products advance through clinical trials, development teams face increasingly complex decisions that shape long-term commercial success. Choices surrounding formulation, container systems, devices, testing, and packaging often made during clinical development can significantly impact scalability, regulatory readiness, patient usability, and overall risk.

Supported by industry-leading device platform providers, container and packaging specialists, and ISO-compliant testing experts, this seminar brings together the technical disciplines required to successfully bridge the clinical to commercial gap.

Engage with experts from PCI Pharma Services, BD, SHL Medical, ZwickRoell and Kymanox. A bonus of registering for this seminar is that attendees will gain a free delegate pass (valued at €680) to BOS Basel taking place on the 30 June -1 July.